SEC Form 4 Summary WWB

ORBIMED ADVISORS LLC buys $20 million in WWB shares

ORBIMED ADVISORS LLC bought 1,176,471 Windward Bio Group AG shares at $17.00 each, for a total value of $20,000,007.00.

Transaction Value:
$20,000,007.00
Shares transacted:
1,176,471
Average price:
$17.00
Insider:

The Form 4 filing, an SEC report of insider stock activity, was filed on November 18, 2026. It identifies ORBIMED ADVISORS LLC as a director and 10% owner of WWB, the ticker for Windward Bio Group AG. The purchase took place on November 16, 2026.

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellbuy
Transaction Count1
Shares Transacted1,176,471
Price$17.00
Total Transaction Value$20,000,007.00
Insider
Ticker SymbolWWB
CompanyWINDWARD BIO GROUP AG
Insider NameORBIMED ADVISORS LLC
Insider TitleDirector, 10% Owner
Sector - IndustryOther - Unclassified
Holdings
Total Shares Owned After Transaction1,708,103
Position Size Change68.88%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

This was a share purchase, reported with transaction code P. ORBIMED ADVISORS LLC bought shares of Windward Bio Group AG in one transaction. The available details do not show whether the purchase took place on an exchange or through a private deal.

What was the average price of the transaction?

The average price was $17.00 per share. That price applies to the one purchase reported for November 16, 2026.

How did this transaction affect the insider's holdings?

The purchase added 1,176,471 shares, leaving 1,708,103 shares reported as owned afterward. The shares bought made up 68.88% of that reported balance after the trade.

What's the total transaction value?

The total transaction value was $20,000,007.00 for the single transaction. That amount matches the reported 1,176,471 shares bought at $17.00 each.

Are there any special circumstances around this transaction?

The available transaction information did not identify a special arrangement. No filing footnotes were provided, so any further terms or explanations remain unknown. The information does not establish why the purchase was made.

Source: SEC Form 4 filing.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.